Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
In the STEP 1 trial, participants without diabetes achieved an average weight loss of approximately 15% of body weight over 68 weeks, compared to 2.4% with placebo
Garcia-Garcia SC, Barbosa-Moreno LE, Martinez-Cabriales SA, Gonzalez-Ramirez RA, Ocampo-Candiani J
The pivotal SURPASS clinical trial program for type 2 diabetes enrolled over 10,000 participants across multiple international sites, demonstrating tirzepatide's efficacy across a range of baseline characteristics and disease severities
Long-Term Success With its emphasis on healthy eating, exercise, and a supportive community, WeightWatchers pushes patients toward long-term success
Significantly , contains high caffeine
US$ 21.49
US$ 23.72
US$ 29.41
US$ 27.38
US$ 25.03
US$ 28.86
